Chemoinformaics analysis of Isorhamnetin 7-glucoside
| Molecular Weight | 478.406 | nRot | 5 |
| Heavy Atom Molecular Weight | 456.23 | nRig | 24 |
| Exact Molecular Weight | 478.111 | nRing | 4 |
| Solubility: LogS | -3.95 | nHRing | 2 |
| Solubility: LogP | 0.254 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 56 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 34 | No. of Aromatic Carbocycles | 2 |
| nHetero | 12 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 22 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 12 | No. of Arom Bond | 17 |
| nHA | 12 | APOL | 61.0334 |
| nHD | 7 | BPOL | 29.8826 |
| QED | 0.254 |
| Synth | 3.965 |
| Natural Product Likeliness | 1.987 |
| NR-PPAR-gamma | 0.951 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.008 |
| Pgp-sub | 0.926 |
| HIA | 0.783 |
| CACO-2 | -6.21 |
| MDCK | 0.0000198 |
| BBB | 0.039 |
| PPB | 0.83591 |
| VDSS | 0.96 |
| FU | 0.128324 |
| CYP1A2-inh | 0.055 |
| CYP1A2-sub | 0.072 |
| CYP2c19-inh | 0.012 |
| CYP2c19-sub | 0.058 |
| CYP2c9-inh | 0.012 |
| CYP2c9-sub | 0.199 |
| CYP2d6-inh | 0.054 |
| CYP2d6-sub | 0.192 |
| CYP3a4-inh | 0.064 |
| CYP3a4-sub | 0.018 |
| CL | 3.261 |
| T12 | 0.754 |
| hERG | 0.028 |
| Ames | 0.808 |
| ROA | 0.041 |
| SkinSen | 0.052 |
| Carcinogencity | 0.228 |
| EI | 0.014 |
| Respiratory | 0.032 |
| NR-Aromatase | 0.908 |
| Antiviral | Yes |
| Prediction | 0.943267 |